COVID-19, PANDEMIC INFLUENZA A(H1N1): CLINICAL AND PATHOLOGICAL COMPARISONS
DOI:
https://doi.org/10.11603/1681-2727.2023.3.14197Keywords:
COVID 19, influenza A(H1N1)pdm09, autopsy, patho-anatomical data, v, acute respiratory distress syndromeAbstract
SUMMARY. The aim of the study. Study of the clinical course and pathomorphological data of influenza A(H1N1)pdm09 and SARS-CoV-2/COVID-19 in a comparative aspect.
Materials and methods. A retrospective study of two independent cohorts of patients who died after infection with either COVID-19 (n=40) or influenza A(H1N1)pdm09 (n=32) and a microscopic study with additional consultation of microspecies of COVID-19 cases (n=12), pandemic flu (n=14). To study the morphological state of the lungs, microscopic examination of sections of lung tissue placed on glass slides, stained with hematoxylin and eosin, and semi-thin sections from blocks prepared for electron microscopic studies were used. Statistical methods are applied, including non-parametric ones (Chi-square, Fisher’s exact test).
The results. Manifestations of the clinical course of influenza A(H1N1)pdm09 (2009, 2010) and COVID-19 (2020, 2021, 2023 cases) were evaluated. Clinical data related to the day of illness during hospitalization, life expectancy, leading risk factors among deceased patients were compared. Pathohistological features of diffuse alveolar damage (DAP), the state of the endothelium of microvessels, hemorrhagic manifestations, formation of blood clots, pulmonary fibrosis were evaluated with an emphasis on the morphological state of the lungs. The results of the pathomorphological examination were analyzed, differences between influenza A(H1N1)pdm09 and COVID-19 were identified.
Conclusions. When comparing the pathohistological features of lungs in deceased patients with SARS-CoV-2/COVID-19 and influenza A(H1N1), differences in lung pathobiology were revealed. During primary morphogenesis in COVID-19, more significant damage to the endothelium is observed during viremia. This, in our opinion, is at the beginning of the formation of “hyaline” membranes, and interstitial pneumonia, and significant pneumofibrosis. Pathomorphological changes in the trachea and bronchi among deceased patients with a diagnosis of influenza were observed more often than in cases of COVID-19. With pandemic flu, people died at a younger age than with COVID-19.
References
Boehm, A. B., Wolfe, M. K., White, B. J., Hughes, B., Duong, D., & Bidwell, A. (2023). More than a Tripledemic: Influenza A Virus, Respiratory Syncytial Virus, SARS-CoV-2, and Human Metapneumovirus in Wastewater during Winter 2022-2023. Environmental science & technology letters, 10 (8), 622–627. https://doi.org/10.1021/acs.estlett.3c00385 DOI: https://doi.org/10.1021/acs.estlett.3c00385
Furlow B. (2023) Triple-Demic Overwhelms Pediatric Units in US Hospitals. Lancet Child & Adolescent Health 7 (2), https://doi.org/10.1016/S2352-4642(22)00372-8. DOI: https://doi.org/10.1016/S2352-4642(22)00372-8
Mboumba Bouassa, R. S., Tonen-Wolyec, S., Veyer, D., Péré, H., & Bélec, L. (2022). Analytical performances of the AMPLIQUICK® Respiratory Triplex assay for simultaneous detection and differentiation of SARS-CoV-2, influenza A/B and respiratory syncytial viruses in respiratory specimens. PloS One, 17(1), e0262258. https://doi.org/10.1371/journal.pone.0262258 DOI: https://doi.org/10.1371/journal.pone.0262258
Luo, J., Zhang, Z., Zhao, S., & Gao, R. (2023). A Comparison of Etiology, Pathogenesis, Vaccinal and Antiviral Drug Development between Influenza and COVID-19. International journal of molecular sciences, 24(7), 6369. https://doi.org/10.3390/ijms24076369 DOI: https://doi.org/10.3390/ijms24076369
Choreño-Parra JA, Jiménez-Álvarez LA, Cruz-Lagunas A, et al. Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza A(H1N1). Front Immunol. 2021;12:593595. Published 2021 Apr 21. doi:10.3389/fimmu.2021.593595 DOI: https://doi.org/10.3389/fimmu.2021.593595
Sagnelli, C., Celia, B., Monari, C., Cirillo, S., De Angelis, G., Bianco, A., & Coppola, N. (2021). Management of SARS-CoV-2 pneumonia. Journal of Medical Virology, 93(3), 1276–1287. https://doi.org/10.1002/jmv.26470 DOI: https://doi.org/10.1002/jmv.26470
Azevedo, M. L. V., Zanchettin, A. C., Vaz de Paula, C. B., Motta Júnior, J. D. S., Malaquias, M. A. S., Raboni, S. M., Neto, P. C., Zeni, R. C., Prokopenko, A., Borges, N. H., Godoy, T. M., Benevides, A. P. K., de Souza, D. G., Baena, C. P., Machado-Souza, C., & de Noronha, L. (2021). Lung Neutrophilic Recruitment and IL-8/IL-17A Tissue Expression in COVID-19. Frontiers in Immunology, 12, 656350. https://doi.org/10.3389/fimmu.2021.656350 DOI: https://doi.org/10.3389/fimmu.2021.656350
Riabokon O. V., Furyk O. O., Riabokon Yu. Yu., Kalashnyk K. V. (2023). Mixed infection of COVID-19 and influenza: current state of the issue. Infectious Diseases 1(111) 2023, 4-11. DOI 10.11603/1681-2727.2023.1.13919 [in Ukrainian]
Rodrigo da Rosa Mesquita, Luiz Carlos Francelino Silva Junior, Fernanda Mayara Santos Santana, Tatiana Farias de Oliveira, Rafaela Campos Alcântara, Gabriel Monteiro Arnozo, Etvaldo Rodrigues da Silva Filho, Aisla Graciele Galdino dos Santos, Euclides José Oliveira da Cunha, Saulo Henrique Salgueiro de Aquino, and Carlos Dornels Freire de Souza. (2020). Clinical manifestations of COVID-19 in the general population: systematic review Wien Klin Wochenschr. 2021;133(7-8): 377–382. Published online 2020 Nov 26. DOI: 10.1007/s00508-020-01760-4 PMCID: PMC7689634 PMID: 33242148 DOI: https://doi.org/10.1007/s00508-020-01760-4
Jiang, C., Yao, X., Zhao, Y., Wu, J., Huang, P., Pan, C., Liu, S., & Pan, C. (2020). Comparative review of respiratory diseases caused by coronaviruses and influenza A viruses during epidemic season. Microbes and Infection, 22 (6-7), 236–244. https://doi.org/10.1016/j.micinf.2020.05.005. DOI: https://doi.org/10.1016/j.micinf.2020.05.005
Mohamed Khosroshahi, L., Rokni, M., Mokhtari, T., & Noorbakhsh, F. (2021). Immunology, immunopathogenesis and immunotherapeutics of COVID-19; an overview. International Immunopharmacology, 93, 107364.https://doi.org/10.1016/j.intimp.2020.107364 DOI: https://doi.org/10.1016/j.intimp.2020.107364
Jansen, A. J. G., Spaan, T., Low, H. Z., Di Iorio, D., van den Brand, J., Tieke, M., Barendrecht, A., Rohn, K., van Amerongen, G., Stittelaar, K., Baumgärtner, W., Osterhaus, A., Kuiken, T., Boons, G. J., Huskens, J., Boes, M., Maas, C., & van der Vries, E. (2020). Influenza-induced thrombocytopenia is dependent on the subtype and sialoglycan receptor and increases with virus pathogenicity. Blood Advances, 4 (13), 2967–2978. https://doi.org/10.1182/bloodadvances.2020001640 DOI: https://doi.org/10.1182/bloodadvances.2020001640
Kamp, J. C., Neubert, L., Ackermann, M., Stark, H., Werlein, C., Fuge, J., Haverich, A., Tzankov, A., Steinestel, K., Friemann, J., Boor, P., Junker, K., Hoeper, M.M., Welte, T., Laenger, F., Kuehnel, M. P., & Jonigk, D. D. (2022). Time-Dependent Molecular Motifs of Pulmonary Fibrogenesis in COVID-19. International Journal of Molecular Sciences, 23(3), 1583. https://doi.org/10.3390/ijms23031583. DOI: https://doi.org/10.3390/ijms23031583
Ackermann, M., Verleden, S. E., Kuehnel, M., Haverich, A., Welte, T., Laenger, F., Vanstapel, A., Werlein, C., Stark, H., Tzankov, A., Li, W. W., Li, V. W., Mentzer, S. J., & Jonigk, D. (2020). Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in COVID-19. The New England Journal of Medicine, 383(2), 120–128. https://doi.org/10.1056/NEJMoa2015432 DOI: https://doi.org/10.1056/NEJMoa2015432
Meyer, N. J., Gattinoni, L., & Calfee, C. S. (2021). Acute respiratory distress syndrome. Lancet (London, England), 398(10300), 622–637. https://doi.org/10.1016/S0140-6736(21)00439-6 DOI: https://doi.org/10.1016/S0140-6736(21)00439-6
Ramadori, G. P. (2022). SARS-CoV-2-Infection (COVID-19): Clinical Course, Viral Acute Respiratory Distress Syndrome (ARDS) and Cause(s) of Death. Medical Sciences (Basel, Switzerland), 10(4), 58. https://doi.org/10.3390/medsci10040058 DOI: https://doi.org/10.3390/medsci10040058
Elsoukkary, S. S., Mostyka, M., Dillard, A., Berman, D. R., Ma, L. X., Chadburn, A., Yantiss, R. K., Jessurun, J., Seshan, S. V., Borczuk, A. C., & Salvatore, S. P. (2021). Autopsy Findings in 32 Patients with COVID-19: A Single-Institution Experience. Pathobiology: Journal of Immunopathology, Molecular and Cellular Biology, 88(1), 56–68. https://doi.org/10.1159/000511325 DOI: https://doi.org/10.1159/000511325
The ARDS Definition Task Force. Acute respiratory distress syndrome: the Berlin Definition //JAMA. June 20 2012; Vol 307 No. 23: 2526–2533. DOI: 10. 1001/jama.2012.5669. DOI: https://doi.org/10.1001/jama.2012.5669
Harris, J. R., Richwood, D., Hames, B. D. Electron microscopy in biology. in the practical approach series. New York, US: Oxford University Press.1991;308.
Gradil, G. I. (2016) Clinical analysis of fatalities from influenza, including a (H1N1) pdm09, in the pandemic and post-pandemic periods (2009-2016). ScienceRise 3 (3 (20), 57-64. DOI:10.15 587/2313-846.65103 DOI: https://doi.org/10.15587/2313-8416.2016.65103
Gubina-Vakulik, G., Gradil, G. (2023) Elements of COVID-19 morphogenesis after the development of viremia in the analysis of sectional cases of early death. 35rd European Congress of Pathology – Abstracts Virchows Archiv European Journal of Pathology (2023) 483 (Suppl 1):S1–S391, September 2023, S.148. DOI: https://doi.org/10.1007/s00428-023-03602-w
Gubina-Vakulik, G., Gradil, G. (2023). Elements of COVID-19 morphogenesis after the development of viremia in the analysis of sectional cases of early death G. Gubina-Vakulik, G. Gradil. KhNMU, Ukraine. 33rd European Congress of Pathology - Abstracts. Virchows Arch. Volume 483 Supplement 1 September 2023. European Journal of Pathology. E-Posters Autopsy Pathology E-PS-01-011
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Г. І. Граділь; Г. І. Губіна-Вакулик, К. В. Юрко, П. В. Нартов, О. П. Лукашова, Ю. Б. Халушева
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal Infectious Disease (Infektsiini Khvoroby) allows the author(s) to hold the copyright without registration
Users can use, reuse and build upon the material published in the journal but only for non-commercial purposes
This journal is available through Creative Commons (CC) License BY-NC "Attribution-NonCommercial" 4.0